Phibro Animal Health Corporation
PAHC
$33.26
-$0.20-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 25.98% | 32.39% | 33.71% | 27.37% | 19.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.98% | 32.39% | 33.71% | 27.37% | 19.12% |
| Cost of Revenue | 25.42% | 31.80% | 33.35% | 26.49% | 15.80% |
| Gross Profit | 27.17% | 33.64% | 34.50% | 29.34% | 26.75% |
| SG&A Expenses | 14.97% | 15.09% | 14.35% | 7.31% | 21.46% |
| Depreciation & Amortization | -20.46% | -20.46% | -20.46% | -20.46% | -1.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.77% | 27.50% | 28.43% | 21.38% | 14.00% |
| Operating Income | 53.73% | 80.52% | 92.98% | 117.32% | 94.37% |
| Income Before Tax | 154.88% | 273.59% | 191.07% | 522.87% | 94.82% |
| Income Tax Expenses | 79.18% | 135.90% | 77.54% | 132.11% | 46.73% |
| Earnings from Continuing Operations | 199.55% | 376.73% | 289.61% | 1,897.68% | 141.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 199.55% | 376.73% | 289.61% | 1,897.68% | 141.54% |
| EBIT | 53.73% | 80.52% | 92.98% | 117.32% | 94.37% |
| EBITDA | 45.35% | 67.30% | 76.99% | 85.45% | 68.46% |
| EPS Basic | 199.41% | 376.49% | 289.39% | 1,895.64% | 141.45% |
| Normalized Basic EPS | 71.49% | 151.88% | 139.39% | 361.39% | 162.05% |
| EPS Diluted | 200.48% | 375.10% | 290.50% | 2,010.34% | 141.82% |
| Normalized Diluted EPS | 70.60% | 150.73% | 138.30% | 360.21% | 161.08% |
| Average Basic Shares Outstanding | 0.06% | 0.05% | 0.03% | 0.01% | 0.01% |
| Average Diluted Shares Outstanding | 0.59% | 0.51% | 0.49% | 0.36% | 0.36% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.67% | -0.79% | -0.74% | -0.95% | -0.59% |